|3Dec 30, 4:12 PM ET

NEXTECH CROSSOVER I SCSP 3

3 · Mersana Therapeutics, Inc. · Filed Dec 30, 2024

Insider Transaction Report

Form 3
Period: 2024-12-20
Holdings
  • Common Stock

    12,067,246
Footnotes (1)
  • [F1]The securities are held of record by Nextech Crossover I SCSp ("Nextech Crossover LP"). Nextech Crossover I GP S.a. r.l. ("Nextech Crossover GP") is the general partner of Nextech Crossover LP and Ian Charoub, Costas Constantinides and Rocco Sgobbo are Managers of Nextech Crossover GP. Nextech Crossover GP and Messrs. Charoub, Constantinides and Sgobbo may be deemed to share voting and investment power with respect to the securities reported herein and disclaim beneficial ownership over such securities, except to the extent of its or his respective pecuniary interest therein, if any.

Documents

1 file
  • 3
    form3-12302024_091214.xmlPrimary